<DOC>
	<DOCNO>NCT03029065</DOCNO>
	<brief_summary>This study aim detect cell free DNA ( cfDNA ) cerebrospinal fluid plasma , determine whether cfDNA use concomitant diagnosis improve treatment efficacy prognosis patient brain ( meningeal ) metastasis monitor tumor-related genetic mutation cfDNA plasma cerebrospinal fluid .</brief_summary>
	<brief_title>Detection CSF Next Generation Sequencing Application Brain Metastases From Lung Adenocarcinoma Meningeal Metastasis</brief_title>
	<detailed_description>This study plan enroll 50 patient lung cancer diagnose brain ( meningeal ) metastases , case slat receive radiotherapy target therapy . Patients ' clinical data collect ( include limit : age diagnosis brain ( meningeal ) metastases , KPS score , smoke history , stage disease diagnosis , time progress brain metastasis , number brain metastasis , extracranial metastasis ( ECM ) , systemic disease time brain metastasis . Anticoagulated whole blood anticoagulated cerebrospinal fluid collect local treatment ( sample primary cancer tissue metastatic carcinoma patient preserve ) 7 day , 1 month , 3 month , well 6 month treatment ( time sample retention determine , Figure 2 ) . DNA extract tumor tissue , genomic DNA extract leukocyte , cfDNA extract plasma cerebrospinal fluid , complete quantitative detection DNA , DNA library construction , well targeted capture sequence . Tumor-related gene analyze , change tumor burden treatment process evaluate . The clinical significance cfDNA plasma cerebrospinal fluid treatment efficacy prognosis evaluate , compare clinical indicator treatment efficacy . This study involve two stage . The first stage pre-experiment : sample retain 3-5 case , mutation tumor-related gene cfDNA plasma cerebrospinal fluid compare . The investigator analyze , combined clinical indicator , whether mutation cfDNA plasma accord cerebrospinal fluid whether mutation cfDNA cerebrospinal reflect mutational status tumor cell . The second phase conduct expand number case , base first stage .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1 . Patients confirm diagnosis lung adenocarcinoma brain ( meningeal ) metastasis . 2 . Samples collection allow . 1 . Pregnant woman 2 . Minors ( subject less 18 year age )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>lung Adenocarcinoma brain ( meningeal ) metastasis</keyword>
</DOC>